Status:
COMPLETED
Effectiveness and Implementation of mPATH-CRC
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Colorectal Cancer
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.
Detailed Description
The study team has developed mPATH-CRC (mobile PAtient Technology for Health-Colorectal Cancer), a patient-friendly iPad program used by individuals immediately before a routine primary care visit. mP...
Eligibility Criteria
Inclusion
- This study will include three distinct populations of participants: 1) healthcare providers and staff at primary care practices, 2) patients aged 18 and older seen in the participating study sites, and 3) patients aged 50-74 seen in the participating study sites who are eligible for CRC screening
- Patient
- Due for routine CRC screening, defined as:
- No colonoscopy within the prior 10 years
- No flexible sigmoidoscopy within the prior 5 years
- No CT colonography within the prior 5 years
- No fecal DNA testing within the prior 3 years
- No fecal blood testing (guaiac-based test with home kit or fecal immunochemical test) within the prior 12 months
- Patient
Exclusion
- Personal history of CRC
- First degree relative with CRC
- Personal history of colorectal polyps
Key Trial Info
Start Date :
October 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2023
Estimated Enrollment :
77145 Patients enrolled
Trial Details
Trial ID
NCT03843957
Start Date
October 31 2019
End Date
March 10 2023
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157